Form 4: Praxis Officer's Routine Stock Withholding for Taxes

Praxis Precision Medicines' Principal Accounting Officer, Lauren Mastrocola, reported a routine disposition of 344 common shares for tax withholding purposes.

Summary

• Lauren Mastrocola, Principal Accounting Officer of Praxis Precision Medicines, Inc., reported a transaction on January 12, 2026.
• 344 shares of Common Stock were disposed of by the Issuer to satisfy tax withholding obligations.
• This withholding was in connection with the vesting of previously reported restricted stock units.
• The shares were valued at $275.74 per share for the transaction.
• Following this transaction, Lauren Mastrocola beneficially owns 13,445.656 shares of Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding related to equity compensation, which is a neutral event and does not indicate positive or negative sentiment about the company's performance or outlook.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to compensation and tax obligations, which is common across all industries for executives receiving equity-based compensation. It does not reflect specific industry trends for the biotechnology or pharmaceutical sector.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders as it is a routine administrative event related to executive compensation and tax compliance. It does not signal a change in company strategy or financial health.

Key Dates

Keywords

Praxis Precision Medicines, PRAX, Insider Transaction, Stock Withholding, Restricted Stock Units, Tax Obligations, Lauren Mastrocola